Privacy Policy
AeroDiary Mobile Application
Document Number | FR-Privacy-A209-01, Rev. 01 |
Company | AeroDel Technology Innovations Private Limited |
Version | 1.0 |
Effective Date | 01 July 2026 |
Privacy Officer | Shradha Sangwai, Quality Director | privacy@aerodeltech.com |
AeroDel Technology Innovations Private Limited ("AeroDel", "we", "us", "our") is committed to protecting the privacy, security, and confidentiality of personal and health information collected and processed through the AeroDiary mobile application ("App"). This Privacy Policy explains how we collect, use, store, share, and protect your information, and how you can exercise your rights over your data.
By downloading, installing, or using AeroDiary, you agree to the practices described in this Privacy Policy. If you do not agree, please do not use the App. This Policy applies to all users worldwide, with jurisdiction-specific provisions for India (DPDP Act 2023), the United States (HIPAA), and the European Union / United Kingdom (GDPR / UK GDPR).
AeroDiary is a Software as a Medical Device (SaMD) companion application designed to help patients and caregivers monitor aerosol therapy adherence, track respiratory symptoms, manage medications, and share therapy data with authorised healthcare professionals. The App is classified as a SaMD under applicable regulatory frameworks including CDSCO (India), FDA (USA), and CE/MDR (EU).
AeroDiary collects sensitive health information. We treat this data with the highest standard of care and process it only for the purposes described in this Policy.
We collect the following categories of information:
The information described above includes "sensitive personal data" (under DPDP Act 2023), "special categories of personal data" (under GDPR), and "protected health information" (PHI, under HIPAA). This includes disease diagnosis, symptom records, and medication data. We collect this data solely to provide and improve the App's medical functionality and only with your explicit, informed consent.
We use your information for the following purposes:
Purpose | Description |
App Functionality | Enable you to log symptoms, track therapy adherence, review score history, search medications, and view health trends. |
Healthcare Professional Sharing | When you explicitly authorise it, share your therapy data with your named healthcare professional(s) to support clinical decision-making. |
Personalisation | Adapt questionnaires and health prompts based on your disease profile and logged history. |
Product Improvement | Analyse aggregated, de-identified usage data to improve App features and therapy monitoring capabilities. |
Post-Market Surveillance | As a SaMD, AeroDiary is subject to post-market surveillance obligations. Anonymised aggregate data may be used to fulfil regulatory reporting requirements under CDSCO, FDA, and MDR. |
Safety and Security | Detect, investigate, and prevent unauthorised access, fraud, and misuse. |
Communications | Send therapy reminders, health alerts, important App updates, and regulatory notices. |
Legal Obligations | Meet obligations under applicable laws including DPDP Act 2023, HIPAA, GDPR, and CDSCO MDR 2017. |
Grievance Resolution | Process and respond to user complaints, access requests, and data deletion requests. |
We process your personal data on the following legal bases, by jurisdiction:
AeroDiary collects health-related information that may constitute Protected Health Information (PHI) under HIPAA when used in connection with healthcare providers. We act as a Business Associate to covered entities (healthcare providers) where applicable, and process PHI under a Business Associate Agreement (BAA). Where HIPAA applies, processing is limited to treatment, payment, and healthcare operations as permitted under 45 CFR Part 164.
We do not sell, rent, or trade your personal or health information. We may share your information only in the following limited circumstances:
Healthcare Professionals (HCPs): With your explicit, in-app authorisation only. You may revoke HCP access at any time from your Profile settings.
Cloud Infrastructure Provider: AeroDiary's data is hosted on DigitalOcean infrastructure. DigitalOcean acts as a data processor under a Data Processing Agreement (DPA). Data is stored in regions selected to meet applicable data residency requirements.
Regulatory Authorities: Where required by law (CDSCO, FDA, EU MDR), including post-market surveillance reporting. Such disclosures will be of aggregated or de-identified data wherever possible.
Law Enforcement / Courts: Where legally compelled by court order, subpoena, or applicable law.
Business Transfers: In the event of a merger, acquisition, or asset sale, your data may be transferred. You will be notified, and your rights will be preserved.
Affiliates and Group Companies: Within AeroDel group entities, bound by the same data protection obligations.
AeroDiary does not integrate with external third-party devices, wearables, or platforms in the current version. All data is processed entirely within AeroDel's own proprietary infrastructure, with no third-party analytics, advertising, or crash-reporting SDKs.
AeroDiary is intended for use by patients of all ages, including children with respiratory conditions such as paediatric asthma. Given the nature of our user base, we apply strict protections for minors:
User data is stored on DigitalOcean servers. AeroDel selects data centre regions to meet applicable data residency requirements:
AeroDel implements the following security controls consistent with IEC 62304, ISO 27001, HIPAA Security Rule, and GDPR Article 32:
Where your data is transferred across international borders, AeroDel ensures appropriate safeguards:
You have the following rights over your personal and health data:
To exercise any of these rights, contact our Privacy Officer at privacy@aerodeltech.com. We will respond within 30 days (or sooner where required by law). Identity verification may be required.
We retain your personal and health data only as long as necessary for the purposes described in this Policy, including to meet legal, regulatory, safety, and post-market surveillance obligations.
Data Category | Retention Period | Basis |
Account and registration data | 5 years after account deletion | DPDP Act 2023 / ISO 13485 |
Health and therapy data | 10 years (or as required by CDSCO/FDA) | Medical device post-market surveillance |
Questionnaire responses and scores | 10 years after last entry | Clinical evidence requirements |
Crash and diagnostic logs | 90 days (rolling) | IEC 62304 software maintenance |
Audit logs (security) | 3 years | ISO 27001 / HIPAA Security Rule |
HCP-shared records | Until revoked + 5 years | Clinical record-keeping standards |
Upon expiry of retention periods, data is securely deleted or anonymised. Anonymised aggregate data may be retained indefinitely for regulatory and safety reporting purposes.
At first launch, AeroDiary presents a Consent screen that obtains your informed, explicit, and freely given consent to collect and process sensitive health data. You may withdraw consent at any time by:
Withdrawal of consent will result in the deletion of your health data and will prevent you from using the App's therapy monitoring features. It will not affect the lawfulness of processing that occurred before withdrawal.
With your permission, AeroDiary sends push notifications for therapy reminders, health alerts, questionnaire prompts, and App updates. You can manage notification preferences at any time in your device's notification settings or within the App's Profile > Notifications settings. Your push notification token is stored on our servers solely to deliver these notifications and is not shared with any third party.
AeroDiary enables you to share your therapy data with authorised healthcare professionals (doctors, nurses, physiotherapists, or other clinicians). The following conditions apply:
We may update this Privacy Policy to reflect changes in our practices, technology, or applicable law. When we make material changes, we will:
Continued use of the App after notification of changes constitutes acceptance of the updated Policy.
For any questions, concerns, access requests, or complaints regarding this Privacy Policy or the processing of your personal data, please contact our Privacy Officer:
Name | Shradha Sangwai |
Designation | Quality Director and Privacy Officer |
Company | AeroDel Technology Innovations Private Limited |
privacy@aerodeltech.com | |
Response Time | Within 30 days of receipt of complaint or request |
If you are located in the European Union or United Kingdom and are not satisfied with our response, you have the right to lodge a complaint with the data protection supervisory authority in your country (e.g., the ICO in the UK, or your local EU DPA).
If you are located in India and are not satisfied with our response, you may escalate to the Data Protection Board of India once established under the DPDP Act 2023.
Prepared By | Reviewed By | Approved By |
Shradha Sangwai | K K Suraj Rajan | Zahir Jaffer |